| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development | $132.0M-21.7% | $168.6M+139.6% | $70.4M+168.0% | $26.3M |
| General and administrative | $38.6M+62.0% | $23.8M+66.6% | $14.3M+173.4% | $5.2M |
| Total operating expenses | $170.6M-11.3% | $192.4M+127.3% | $84.7M+168.9% | $31.5M |
| Loss from operations | -$170.6M+11.3% | -$192.4M-127.3% | -$84.7M-168.9% | -$31.5M |
| Interest income, net | $16.0M+9.4% | $14.6M+14.4% | $12.8M+661.1% | $1.7M |
| Other income | $0-100.0% | $5K+66.7% | $3K-25.0% | $4K |
| Total other income, net | $16.0M+9.3% | $14.6M+14.4% | $12.8M+659.5% | $1.7M |
| Net loss | -$154.7M+13.0% | -$177.8M-147.3% | -$71.9M-141.3% | -$29.8M |
| Net loss per share attributable to common stockholders - basic (in USD per share) | -$2290.00+37.4% | -$3660.00-83.9% | -$1990.00+65.5% | -$5770.00 |
| Net loss per share attributable to common stockholders - diluted (in USD per share) | -$2290.00+37.4% | -$3660.00-83.9% | -$1990.00+65.5% | -$5770.00 |
| Weighted-average shares used to compute net loss per share attributable to common stockholders - basic (in shares) | $67656355000.00+39.4% | $48539795000.00+34.1% | $36188254000.00+600.3% | $5167296000.00 |
| Weighted-average shares used to compute net loss per share attributable to common stockholders - diluted (in shares) | $67656355000.00+39.4% | $48539795000.00+34.1% | $36188254000.00+600.3% | $5167296000.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.